The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD(+) Cleavage Activity that Promotes Pathological Axonal Degeneration
[PMID: 14755637] PubMed record related to this compound for laboratory literature review
No lethal dose has been identified
The incidence of new cases is approximately 12 per 100,000 people per year and women are impacted more than men
Given the ICD10 diagnosis codes (R79.0, Z79.899, R53.83, Z13.220, E11.43, G62.9, I83.813, I10, E78.2, E66.01, M62.838, M54.9, M25.512, L68.0, M25.562, Z13.29, E28.2, G47.9) and the laboratory tests (IGF1, progesterone, FSH, TPO antibody, homocysteine, reverse T3 LC/MS/MS, CRP, DHEA LC/MS, comprehensive metabolic panel, CBC with differential, estradiol, hemoglobin A1c, lipid panel with calculated LDL, vitamin D 25OH, insulin, ferritin/iron/transferrin/TIBC, free testosterone, random cortisol, total testosterone, free T3, free T4, TSH, vitamin B12), which diagnosis codes can be used to justify billing for each lab test?
Vogiatzoglou, A